background image

Paid Clinical Trials Fargo

Discover 175 paid clinical trials in Fargo, North Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: 90 recruiting locations
Sponsor: Cleerly, Inc.

Sex: All

Age: 55+

Code: NCT06112418

Recruiting
Active & Responsive

Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

for
Age-Related Macular Degeneration
Location: 3 recruiting locations
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 50+

Code: NCT06924021

Recruiting
Active & Responsive

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

for
Diabetes Mellitus, Type 2, Hypertension,
Location: 116 recruiting locations
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07064473

Phase3, Recruiting
Active & Responsive

Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

for
Knee Injuries, Pain, Postoperative, Opioid Use
Location: 1 recruiting location
Sponsor: Sanford Health

Sex: All

Age: 18 - 70+

Code: NCT03858231

Recruiting
Active & Responsive

Taldefgrobep Alfa in Adults With Overweight and Obesity

for
Obesity, Overweight
Location: 19 recruiting locations
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 65

Code: NCT07281495

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

for
Atopic Dermatitis (AD), Psoriasis (PsO)
Location: 2 recruiting locations
Sponsor: LAPIX Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06982352

Phase1, Recruiting
Active & Responsive

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

for
Non-small Cell Lung Cancer (NSCLC)
Location: 18 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06305754

Phase3, Recruiting
Active & Responsive

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

for
Carcinoma, Non-Small-Cell Lung
Location: 12 recruiting locations
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04165798

Recruiting

Alcohol Related Impairment and Reinforcement: Pre to Post Roux en Y Gastric Bypass Surgery

for
Bariatric Surgery Candidate
Location: 1 recruiting location
Sponsor: Neuropsychiatric Research Institute, Fargo, North Dakota

Sex: All

Age: 21 - 65

Code: NCT02370732

Recruiting

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

for
Cancer
Location: 26 recruiting locations
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT06207032

Recruiting